BCL2 and prostate carcinoma: To validate the correlation between SSA and prostate cancer targets, molecular docking was performed between SSA and key targets of prostate cancer, and the results showed that the binding energies between SSA and BCL2, ESR1, HIF1A, and STAT3 were all less than −6 kcal/mol, signifying that these key targets spontaneously bind to SSA.